Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Biomedicine (Taipei) ; 5(1): 5, 2015.
Article in English | MEDLINE | ID: mdl-25705585

ABSTRACT

As a major component of the cell wall of Gram-negative bacteria, lipopolysaccharide (LPS) can be released into the bloodstream to cause a spectrum of pathophysiological reactions. Despite the fact that colon epithelium cells in situ are continuously exposed to LPS, their biological responses as provoked by LPS as well as the underlying mechanisms are poorly defined. In the present study, we observed that LPS directly stimulated growth of Caco-2 cells as well as enhanced the amounts of c-Src, which could be partly attributable to increased c-src transcript. Parallel to LPS-induced c-Src expression was FAK activation and ERK activation. Remarkably, activation of ERK and cellular proliferation by LPS could be inhibited by PP2, the specific Src inhibitor, implicating the essential role of c-Src in this process. To our knowledge, this is the first report indicating that LPS can increase cellular growth via upregulation of c-Src in colon epithelial cells.

2.
Mol Immunol ; 43(4): 308-16, 2006 Feb.
Article in English | MEDLINE | ID: mdl-15869794

ABSTRACT

As tyrosine kinases are indispensable in lipopolysaccharide (LPS)-induced macrophage activation, the myeloid-specific Src members (i.e. Lyn, Fgr and Hck) are speculated to play important roles in this process. However, the normal LPS responsiveness in lyn(-/-)fgr(-/-)hck(-/-) macrophages implicates the presence of an elusive, compensating tyrosine kinase(s). In this study, we demonstrate the upregulation of c-Src in Raw264.7 and peritoneal macrophages (PEMs) by LPS, which is inhibited by PP2 (an inhibitor for Src family kinases), pyrrolidinedithiocarbamate (PDTC; NF-kappaB inhibitor) and LY294002 (PI3K inhibitor). And this LPS-mediated c-Src induction is also observed in macrophages recovered from LPS-challenged rats. Intriguingly, PP2 attenuates the ability of PEMs to elicit COX-2 expression and nitric oxide production in response to LPS. Similar results are also observed when macrophages recovered from rats receiving either LPS alone or LPS and PP2 both are compared. Furthermore, administration of PP2 in Raw264.7 and animal models of sepsis greatly suppresses TNFalpha secretion and serum TNFalpha level, respectively. Therefore, we conclude that c-Src, with its LPS induction, has an unperceived role in transmitting LPS signaling in macrophages.


Subject(s)
Genes, src , Lipopolysaccharides/pharmacology , Macrophage Activation/drug effects , Macrophages/drug effects , Nitric Oxide/metabolism , Tumor Necrosis Factor-alpha/metabolism , Animals , Cell Line/drug effects , Cell Line/metabolism , Chromones/pharmacology , Cyclooxygenase 2/metabolism , Endotoxemia/metabolism , Endotoxemia/physiopathology , Flavonoids/pharmacology , Gene Expression Regulation , Lipopolysaccharides/toxicity , Macrophage Activation/physiology , Macrophages/metabolism , Macrophages, Peritoneal/drug effects , Macrophages, Peritoneal/metabolism , Mice , Morpholines/pharmacology , NF-kappa B/antagonists & inhibitors , Peritonitis/pathology , Phosphoinositide-3 Kinase Inhibitors , Proline/analogs & derivatives , Proline/pharmacology , Pyrimidines/pharmacology , Rats , Rats, Sprague-Dawley , Signal Transduction/drug effects , Thiocarbamates/pharmacology , src-Family Kinases/antagonists & inhibitors , src-Family Kinases/deficiency , src-Family Kinases/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...